Advances in Biopharmaceutical Technology in China - Current Year or Most Recent Edition.

Advances in Biopharmaceutical Technology in China - Current Year or Most Recent Edition.
Product Code: BioPlan-ChinaBiopharma
Availability: In Stock
Price: $6,750.00
A Society for Industrial Microbiology and BioPlan Associates co-publication China is becoming increasingly important to international biopharmaceutical companies and suppliers, according to the new peer-reviewed, joint Society for Industrial Microbiology publication, Advances in Biopharmaceutical Technology in China. The study describes how China is likely to become one of the world's top pharmaceutical markets in the next 10 years, and what Chinese industry and government plan to do over the next 25 years to ensure success. China is investing $6 billion in biopharmaceutical development projects, and will likely create the world's largest market for vaccines, and one of the largest consumer markets for biopharmaceuticals.

Every organization has a China strategy, though for many of us it is simply “ignore it.” A great opportunity exists in working with China and implementing an effective company strategy. However, winning in Asia in the new millennium will require fundamental changes in partnerships between western and Asian companies. Every company faces the question “What should our China strategy be?” But to neglect China is to forego opportunities to gain efficiency in most of the things we are trying to do. China provides opportunities that allow us to do different things and not just do things differently. This volume provides an overview of the biopharmaceutical industry, and the state of technology. It will help the reader understand general business practice in China, analyze business opportunities and in identifying potential partners for working in China. It provides a ready reference for all aspects of the world of biopharmaceuticals in China, including general understanding, detailed technical and business descriptions, and detailed information on all types of organizations involved in biopharmaceuticals in China, whether they be companies (state owned or privately owned), universities, or government institutions.
Copyright © All rights reserved.